MDBH MDB CAPITAL HOLDINGS LLC

MDB Capital Holdings Provides Second Quarter 2025 Update

MDB Capital Holdings Provides Second Quarter 2025 Update

Management to Host Conference Call Today at 4:30 p.m. ET

Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025, and subsequent developments.

Second Quarter 2025 and Subsequent Operational Highlights

  • Launched private offering for Paulex Bio, a company developing a transformational oral medication designed to eliminate the root cause of diabetes.
  • Announced our next IPO and filed S-1 for Buda Juice, which is redefining the fresh juice category with UltraFresh™ cold-crafted juices.
  • Deepened our pipeline of early-stage, disruptive companies capable of becoming leaders in new categories.
  • Announced new strategic partnership with Keiretsu Forum MST to drive IPO Angels, a platform that will further expand MDB’s investor community.
  • Broadened relationships with RIAs to reach new investors with large equity portfolios looking for new strategies to gain venture exposure.
  • Announced plans to spin-out PatentVest, the “next generation” IP law firm, as an independent public company in 2026 to further leverage this unique asset and create value for MDB.

“We’re betting that the public markets are the place to be for emerging companies as the traditional venture and private equity markets are under significant restructuring,” said Christopher Marlett, CEO and Co-Founder of MDB Capital Holdings. “We’re excited to launch more visionary companies on public markets and provide investors with additional public venture opportunities.”

Second Quarter 2025 Update Zoom Webinar at 4:30 p.m. ET Today

Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, and anticipated milestones, as well as host a question-and-answer session.

Investors can pre-register now for the Zoom webinar . The live webinar will also be accessible  on the day of the event through MDB’s investor relations website at .

About MDB Capital Holdings, LLC

Founded in 1997, MDB Capital focuses on launching "Big Ideas" into valuable public companies with a better approach to public venture capital. This approach leverages community-driven financings of early-stage emerging leaders in meaningful business and technology categories via early public offerings, primarily listed on NASDAQ, as well as post-IPO offerings for companies that align with MDB's overall investment criteria.

MDB Capital is the brand under which MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries operate. Its subsidiaries includes MDB Capital, a venture-focused broker-dealer with MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm dedicated to transforming innovation into market value. MDB Capital is a registered broker-dealer, Member FINRA/SIPC.

For more information, please visit .

Forward-Looking Statements

This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

Investor Relations Contact:



Media Contact:





EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides Second Quarter 2025 Update

MDB Capital Holdings Provides Second Quarter 2025 Update Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025, and subsequent developments. Second Quarter 2025 and Subsequent Operational Highlights Launched private offering for Paulex Bio, a company developing a transformational oral medication designed to eliminate th...

 PRESS RELEASE

PatentVest and Docana Announce Strategic Partnership to Accelerate IP ...

PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- PatentVest, Inc., a leader in intellectual property strategy and prosecution, announces a strategic partnership with Docana, Inc., an emerging innovator in AI-powered enterprise knowledge extraction. This collaboration represents a shared commitment to advancing scalable innovation through the integration of robust IP frameworks and cutting-edge artificial intelligence. As part of the partnership, PatentVest will provide strategic legal and IP co...

 PRESS RELEASE

PatentVest Releases First-Ever Quantum Computing Rankings

PatentVest Releases First-Ever Quantum Computing Rankings Designed for investors, board members, and CEOs, the latest PatentVest Pulse Report reveals which companies are emerging as true leaders as quantum computing shifts from R&D to commercialization Addison, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and legal strategy firm, today announced the release of its , the first-ever rankings of leadership in the emerging $850B quantum computing market. Designed for investors, board members, and CEOs, the report profiles 38 companies worldwid...

 PRESS RELEASE

MDB Capital Holdings to Host Second Quarter 2025 Update Conference Cal...

MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time Addison, TX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday August 27, 2025 at 4:30 p.m. Eastern Time to provide a business update for the second quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead ...

 PRESS RELEASE

New PatentVest Pulse Report Maps the Competitive and IP Landscape of t...

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who’s actually leading and why in one of the most underpenetrated markets in medtech DALLAS, TX , July 10, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP strategy and legal firm, today announced the release of a new report that maps the most important shift in medtech since the rise of the da Vinci system. Built from analysis of more than 18,000 patent families, $4B in M&A activit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch